TrademarkDir
SYRIQ
LIVE

Serial Number

79141907

Owner

SCHOTT Pharma AG & Co. KGaA

Attorney

Thomas E. Zutic

Filing Date

Nov 27, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SYRIQ Trademark

Serial Number: 79141907 • Registration: 4590864

SYRIQ is a trademark filed by SCHOTT Pharma AG & Co. KGaA on November 27, 2013. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SCHOTT Pharma AG & Co. KGaA (12 trademarks)

Hattenbergstrasse 10

Entity Type: 99

SCHOTT AKTIENGESELLSCHAFT (91 trademarks)

10 HATTENBERGSTRASSE
D-55122 MAINZ 55122 , DE

Entity Type: 09

Trademark Details

Filing Date

November 27, 2013

Registration Date

August 26, 2014

Published for Opposition

June 10, 2014

Goods & Services

Syringes for medical purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Nov 20, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Nov 20, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 18, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 28, 2024 ES75
INTERNATIONAL REGISTRATION RENEWED
Nov 23, 2023 RNWL
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 26, 2023 REM4
CHANGE OF OWNER RECEIVED FROM IB
Feb 4, 2023 CHLD
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 5, 2020 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 5, 2020 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 22, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 23, 2020 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 9, 2019 REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 26, 2019 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2015 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 2, 2015 FICS
FINAL DISPOSITION PROCESSED
Feb 2, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Jun 6, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 21, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 21, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 21, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 5, 2014 PREV
ASSIGNED TO LIE
Apr 30, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2014 TROA
REFUSAL PROCESSED BY IB
Mar 14, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 26, 2014 RFCS
REFUSAL PROCESSED BY MPU
Feb 26, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 22, 2014 RFCR
NON-FINAL ACTION WRITTEN
Feb 21, 2014 CNRT
ASSIGNED TO EXAMINER
Feb 18, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 4, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 31, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 30, 2014 REPR

Related Trademarks

More from this Owner

SYRIQ XLINK

SYRIQ XLINK

SYRIQ BIOPURE XLINK

SYRIQ BIOPURE XLINK

D 263 logo

D 263

PHARMAVERSITY

PHARMAVERSITY

PHARMAVERSITY

PHARMAVERSITY

PHARMAVERSITY

PHARMAVERSITY